YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
88 hedge funds and large institutions have $266M invested in Y-mAbs Therapeutics in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $394M → $266M (-$128M)
38% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 24
Holders
88
Holding in Top 10
2
Calls
$2.68M
Puts
–
Top Buyers
| 1 | +$12.2M | |
| 2 | +$10.1M | |
| 3 | +$5.28M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.76M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.33M |
Top Sellers
| 1 | -$28M | |
| 2 | -$25.6M | |
| 3 | -$4.05M | |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$2.52M |
| 5 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$1.94M |